<?xml version="1.0" encoding="UTF-8"?>
<ref id="bib29">
 <label>29</label>
 <element-citation publication-type="other" id="sref29">
  <person-group person-group-type="author">
   <collab>National Health Surveillance Agency (Anvisa), Brazil Ministry of Health</collab>
  </person-group>
  <article-title>Resolution 346: Defines the Extraordinary and Temporary Criteria and Procedures for the Certification of Good Manufacturing Practices for the Purposes of Registration and Post-Registration Changes of Active Pharmaceutical Ingredient, Medication and Health Products Due to the International Public Health Emergency of the New Coronavirus [DO Online]</article-title>
  <comment>Available at:</comment>
  <ext-link ext-link-type="uri" xlink:href="https://www.tuv.com/regulations-and-standards/en/brazil-anvisa-resolution-rdc-346-2020-with-alternative-gmp-auditing-(good-manufacturing-practice).html" id="srct0010b" xmlns:xlink="http://www.w3.org/1999/xlink">https://www.tuv.com/regulations-and-standards/en/brazil-anvisa-resolution-rdc-346-2020-with-alternative-gmp-auditing-(good-manufacturing-practice).html</ext-link>
  <year>March 13, 2020</year>
 </element-citation>
</ref>
